Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

The safety and pharmacokinetics of weekly dapsone and weekly dapsone plus pyrimethamine were examined in adult patients with human immunodeficiency virus infection who were at risk for pneumocystis pneumonia because of a prior episode or a CD4+ T-cell count less than 250 cells per mm3. Groups of pat...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Falloon, J, Lavelle, J, Ogata-Arakaki, D, Byrne, A, Graziani, A, Morgan, A, Amantea, M A, Ownby, K, Polis, M, Davey, R T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1994
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284596/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7979291/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.7.1580
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!